Log in

Lenvatinib Treatment - Thyroid Cancer

Lenvatinib - Differentiated Thyroid Cancer Treatment

Please follow this link to learn about Lenvatinib for Differentiated Thyroid Carcinoma.

This treatment is currently not reimbursed on the PBS for thyroid cancer (Differentiated Thyroid Carcinoma). However, please read about the Lenvatinib Clinical Trial.

Please discuss this treatment with your treating doctor if you think it may be suitable for you.

Consumer Medicine Information (CMI) is available here.


Tel: +61 (0) 447 834 724

Email: info@thyroidfoundation.org.au

Mailing Address:

PO Box 36

Narellan NSW 2150



The mission of The Australian Thyroid Foundation Ltd (ATF) is to offer support, information and education to members and their families through the many services provided by The ATF and raise awareness about health consequences of iodine deficiency and the benefits of good thyroid health.

© 2021 Australian Thyroid Foundation - All donations of $2.00 or more to are tax deductiblePrivacy Policy | Terms & Conditions

Powered by Wild Apricot Membership Software